Allscripts Healthcare Solutions - MDRX Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last twelve months. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDRX shares.
View MDRX analyst ratings or view top-rated stocks.

6 analysts have issued 1-year target prices for Allscripts Healthcare Solutions' shares. Their MDRX share price forecasts range from $17.00 to $26.00. On average, they anticipate the company's share price to reach $22.00 in the next year. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for MDRX or view top-rated stocks among Wall Street analysts.

Allscripts Healthcare Solutions' stock was trading at $18.45 at the beginning of the year. Since then, MDRX shares have increased by 0.5% and is now trading at $18.55.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our MDRX earnings forecast.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) posted its quarterly earnings results on Thursday, November, 3rd. The software maker reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.19 by $0.04. The software maker had revenue of $151.90 million for the quarter, compared to analyst estimates of $152.79 million. Allscripts Healthcare Solutions had a net margin of 7.25% and a trailing twelve-month return on equity of 10.74%. The firm's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.21 earnings per share.

Allscripts Healthcare Solutions announced that its Board of Directors has approved a share buyback program on Wednesday, May 26th 2021, which allows the company to buyback $350,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 14% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its shares are undervalued.

796 employees have rated Allscripts Healthcare Solutions Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (19.06%), Vanguard Group Inc. (12.40%), Dimensional Fund Advisors LP (8.36%), Fisher Asset Management LLC (4.86%), State Street Corp (3.80%) and Jacobs Levy Equity Management Inc. (1.46%). Insiders that own company stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends.

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDRX stock can currently be purchased for approximately $18.55.

Allscripts Healthcare Solutions (NASDAQ:MDRX) has a market capitalization of $2.03 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

The company employs 8,000 workers across the globe.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.